Salesforce Friends ...
Health Care: Drugs
Dendreon Corp (DNDN: NASDAQ)
$5.91 -0.85 | -12.57%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -337.81M | -439.48M | -220.16M | -71.64M |
| Operating Gains/Losses | 0.00 | 142.57M | 118.76M | -376.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -22.86M | -12.68M | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | -17.56M | -17.05M | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -40.00K | 5.59M | 2.02M | -1.98M |
| (Decrease) Increase In Other Current Liabilities | 21.35M | 10.84M | 16.86M | -6.45M |
| (Increase) Decrease In Other Working Capital | 4.75M | -82.00K | -82.00K | 1.23M |
| Other Non-Cash Items | 76.22M | 46.60M | 17.21M | 6.29M |
| Net Cash From Continuing Operations | -242.30M | -267.47M | -85.52M | -66.05M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -242.30M | -267.47M | -85.52M | -66.05M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 51.29M |
| Purchases of Property, Plant & Equipment | -25.42M | -140.76M | -65.91M | -6.82M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -71.82M | -90.11M | -212.11M | -11.06M |
| Issuance of Debt | 607.13M | 0.00 | 3.85M | 700.00K |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 9.04M | 83.28M | 646.84M | 66.97M |
| Repayment of Long-Term Debt | -6.57M | -2.64M | -2.75M | -6.76M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.38M | 112.00K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 608.22M | 80.75M | 647.94M | 60.91M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 294.10M | -276.83M | 350.31M | -16.20M |
Portfolios with DNDN
- Portfolio NameUser Type
- UserLong Term Stock Picks
- UserTop 10 Small Cap Stock Picks
- ContributorBreakout Stocks Of The Week...
- UserS ACCT
- UserRISK
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorRelative Strength Trades fo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
Latest DNDN Headlines from TheStreet
- Dendreon Stock Hits New 52-Week Low (DNDN) 06.04.12 | 10:06 am
- ASCO 2012 Live Blog -- Monday 06.04.12 | 06:06 am
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- ASCO 2012 Live Blog -- Saturday 06.02.12 | 07:06 am
- J&J Scores Big With Prostate Cancer Pill 06.02.12 | 12:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- The Next Big Thing in Biotech: ASCO Conference
05.25.12 | 05:05 am - Dendreon Management Presents At Bank Of America Merrill Lynch 2012 Health Care Conference (Transcript) 05.17.12 | 01:05 am
- Dendreon Management Presents At Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript) 05.11.12 | 07:05 pm
- Dendreon Stock Gaps Down On Today's Open (DNDN) 05.08.12 | 08:05 am
Press Releases for DNDN
- Dendreon Announces Webcast Presentations At Upcoming Conferences - Business Wire 05.25.12 | 08:05 pm
- Dendreon Announces Data Presentation At The 2012 American Urological Association Annual Meeting - Business Wire 05.21.12 | 10:05 am
- Dendreon Announces Presentation Of PROVENGE Data At The 2012 American Society Of Clinical Oncology Annual Meeting - Business Wire 05.16.12 | 06:05 pm
- Dendreon Reports Net PROVENGE Product Revenues Of $82 Million, Achieved 6.5% Quarter-Over-Quarter Growth - Business Wire 05.07.12 | 04:05 pm
- Jennerex Elects Dr. Mitchell H. Gold To Board Of Directors - PR Newswire 04.17.12 | 07:04 am
- Dendreon To Host Conference Call On May 7 To Announce First Quarter Financial Results And Webcast Presentations At Upcoming Conferences - Business Wire 04.09.12 | 05:04 pm
- Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop As Executive Chairman Of The Board - PR Newswire 03.22.12 | 08:03 am
- Dendreon Announces Webcast Presentation At Upcoming Conferences - Business Wire 03.05.12 | 08:03 am
- Dendreon Announces Executive Appointments - Business Wire 02.28.12 | 05:02 pm
- Dendreon Reports Fourth Quarter And 2011 Year End Financial Results - Business Wire 02.27.12 | 08:02 am
Partner Headlines for DNDN
- Analyst Alerts: General Motors, Valero, Copa Holdings, Dendreon June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Active Stock Alerts: Dendreon, Delcath Systems, Johnson & Johnson, Boeing, Onyx June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Stock Insights: Dendreon, Medtronic, FedEx, ArQule, Rentrak June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Social Media Outlook for Monday June 4 (AUXL, NFLX, DNDN, IBM) - Benzinga 06.04.12 | 09:06 am
- Healthcare Business Recap: Dendreon BOMBS, Cancer Cures Galore - Wall St. Cheat Sheet 06.04.12 | 06:06 am
- J&J and 2 Dow 30 Stocks BUZZING Now - Wall St. Cheat Sheet 06.04.12 | 04:06 am
- 3 BOMBS Getting Dropped on Dendreon Now - Wall St. Cheat Sheet 06.04.12 | 03:06 am
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Analyst Alerts: VeriFone, Dendreon, TD Bank May 25th - Wall St. Cheat Sheet 05.25.12 | 11:05 am
